Sign In
Buy AGRX
$1.51
+0 (+0%)
At Close: Nov 25, 2024
33 Stocks Moving in Friday's Pre-Market Session
12:15pm, Friday, 21'st Feb 2020
Gainers
Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 30% to $10.40 in pre-market trading after the company reported the FDA approval of ANJESO for management of moderate to...
8 Stocks To Watch For February 21, 2020
09:55am, Friday, 21'st Feb 2020
Some of the stocks that may grab investor focus today are: Wall Street expects Deere & Company (NYSE: DE ) to report quarterly earnings at $1.26 per share on revenue of $6.42 billion before the openin
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
09:14pm, Thursday, 20'th Feb 2020
Agile Therapeutics, Inc. (AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All shares being offe
Agile Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
09:01pm, Thursday, 20'th Feb 2020
Current Cash and Cash Equivalents Expected to Meet Projected Operating Requirements through End of 2020 Twirla®, Company’s Lead Product Candidate, Receives FDA Approval.
35 Healthcare Stocks Moving In Tuesday's Pre-Market Session
01:25pm, Tuesday, 18'th Feb 2020
Gainers
Stealth BioTherapeutics, Inc. (NASDAQ: MITO) stock increased by 38.4% to $3.10 during Tuesday's pre-market session. According to the most recent rating by H...
Agile Could Reach $10/Share After Twirla Approval
12:48am, Tuesday, 18'th Feb 2020
Agile Therapeutics received FDA approval for its Twirla contraceptive patch last week. The FDA approval is as expected with required post-marketing studies; the
H.C. Wainwright Maintains Buy on Agile Therapeutics, Raises Price Target to $7
12:00am, Tuesday, 18'th Feb 2020The Week Ahead In Biotech: Agile, Baudax Bio, Merck and Esperion Await FDA Decisions
08:03pm, Sunday, 16'th Feb 2020
Biotech stocks were quiet in the week ending Feb. 14 amid some data readouts at a couple of conferences and earnings news flow from smid-cap companies. The following are key biotech catalysts to look
Twirla® is a new non-daily, non-invasive contraceptive approved in the U.S. PRINCETON, N.J., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (AGRX) (Agile or the Company), a forward-th
FDA Approves Agile Therapeutics, Inc.'s Twirla® (levonorgestrel and ethinyl estradiol) ...
12:00am, Friday, 14'th Feb 2020Mid-Morning Market Update: Markets Open Lower; PepsiCo Tops Q4 Views
03:24pm, Thursday, 13'th Feb 2020
Following the market opening Thursday, the Dow traded down 0.5% to 29403.49 while the NASDAQ fell 0.36% to 9691.30. The S&P also fell, dropping 0.33% to 3,368.18.
Leading and...
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
01:05pm, Thursday, 13'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) AbbVie Inc (NYSE: ABBV ) Agile Therapeutics Inc (N
